Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAddition of Revision: v3.5.0 and deletion of Revision: v3.4.3 in the page history.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe 2026-03-04 revision (v3.4.3) adds Contacts/Locations and Study Status entries to the record history.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry v3.4.2 was added to the history and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.4.1 was added to the page footer and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision: v3.4.1 was added to the history and Revision: v3.4.0 was removed. This update affects only the site's release notes on the history page.SummaryDifference0.0%

- Check66 days agoChange DetectedUI enhancements were introduced: a glossary display and color-coded change highlights (green for additions, red for deletions) with a revision note updated to v3.4.0. Additionally, capitalization of 'No FEAR Act Data' was corrected and the older 'No FEAR Act data' phrasing removed.SummaryDifference0.1%

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.